BROOKE CAST: Open Payments
NPI 1386663722 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,381 in 88 payments from 17 companies in 2025. Trend: 2023 $179 · 2024 $1,486 · 2025 $1,381
Food & beverage: $1,361Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $334 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $219 |
| Madrigal Pharmaceuticals | 12 | $154 |
| Janssen Biotech, Inc. | 10 | $152 |
| Ipsen Biopharmaceuticals, Inc | 4 | $98 |
| Gilead Sciences, Inc. | 4 | $96 |
| Lilly USA, LLC | 3 | $72 |
| Phathom Pharmaceuticals, Inc. | 8 | $67 |
| ARGENX US, INC. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
Products named: ENTYVIO, REZDIFFRA, TREMFYA, RINVOQ, IQIRVO, SKYRIZI, OMVOH, VOQUEZNA.
Industry payments across NE — which companies pay providers there.
